1 min read

Swiss Biotech Day

Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024 

With nearly 30 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.  

If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing,  biostatistical,or pharmacovigilance support  for your programs – Veristat can help. 

As a flexible CRO and consultancy, we provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies.  Our acquisition of SFL extends our capabilities into public affairs, market access, and healthcare compliance, with team members deeply embedded in the EU, UK and Swiss healthcare ecosystem.  

Don't miss this opportunity to connect with us and learn more about how Veristat is making a difference in the lives of patients with rare and ultra-rare diseases.

The Science-First CRO.™

The scientific full service CRO and consultancy integrating strategic planning, regulatory strategy, and clinical trial execution to rapidly advance your complex or novel therapies.

Schedule A Meeting

Veristat team member, Delphine Guérin, Senior Business Development Director, will be at the venue, ready to listen to your needs and share Veristat’s expertise.  
You can arrange a meeting by completing the form on the right side of this page. Explore our wide range of capabilities and discover how we can advance your programs to a successful outcome. 

Conference Details



Share This Event:


1 min read

Chief Medical Officer Summit -CMO 360°

Meet the Veristat team at Booth #3, April 17th and 18th in Boston

The Science-First CRO™ and Consultancy Ready to...

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...